Edition:
United Kingdom

Epizyme Inc (EPZM.OQ)

EPZM.OQ on NASDAQ Stock Exchange Global Select Market

12.68USD
18 Apr 2019
Change (% chg)

$0.06 (+0.48%)
Prev Close
$12.62
Open
$12.59
Day's High
$12.86
Day's Low
$12.27
Volume
235,477
Avg. Vol
287,943
52-wk High
$18.65
52-wk Low
$5.14

About

Epizyme, Inc. is a clinical-stage biopharmaceutical company. The Company discovers, develops and plans to commercialize epigenetic therapies for cancer patients. The Company is engaged in the discovery and development of novel epigenetic therapies for cancer patients. The Company develops small molecule inhibitors of a class of... (more)

Overall

Beta: 2.21
Market Cap(Mil.): $1,257.42
Shares Outstanding(Mil.): 67.79
Dividend: --
Yield (%): --

Financials

  EPZM.OQ Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -2.06 -- --
ROI: -51.70 8.91 13.83
ROE: -59.18 10.06 15.25

CORRECTED-BRIEF-Epizyme Reports Q3 Loss of $0.54 Per Share

* EPIZYME REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS AND TAZEMETOSTAT PROGRESS

02 Nov 2018

Earnings vs. Estimates